论文部分内容阅读
目的探讨白三烯受体拮抗荆孟鲁司特治疗小儿支气管哮喘的疗效。方法对收治的90例支气管哮喘患儿随机分为治疗组和对照组。对照组给予常规治疗,治疗组在对照组治疗的基础上加用孟鲁司特钠治疗。治疗3个月后比较2组疗效。结果治疗组和对照组的临控、显效、好转、无效例数分别为8、20、14、3和3.18、13、Ⅱ。结论孟鲁司特钠治疗小儿支气管哮喘的疗效显著,值得临床推广应用。
Objective To investigate the efficacy of leukotriene receptor antagonist Jingrulutete in children with bronchial asthma. Methods Ninety cases of bronchial asthma were randomly divided into treatment group and control group. Control group given conventional treatment, the treatment group in the control group based on the treatment plus montelukast sodium. After 3 months of treatment, the two groups were compared. Results The treatment group and control group, the control, markedly effective, improved, invalid cases were 8,20,14,3 and 3.18,13, Ⅱ. Conclusion Montelukast sodium treatment of children with bronchial asthma significant effect, worthy of clinical application.